A critical review of Chinese vaccine enterprises in the global aid market: evolution, drivers, and structural constraints.

ABSTRACT: The Chinese government has assumed an increasingly prominent role in global health governance in recent years, yet the engagement of Chinese enterprises remains underexplored. Existing studies have largely focused on Beijing's major initiatives during the COVID-19 pandemic, overlooking the evolving role of Chinese enterprises as non-state actors. This article provides a comprehensive review of the participation of Chinese vaccine companies in the global aid market, with particular attention to their changing roles, underlying motivations, and persistent challenges as latecomers from the Global South. Drawing on around 80 industry and policy documents, publicly available datasets, and 10 semi-structured interviews with industry and government stakeholders, this study uses documentary synthe

SUBMITTER: Ding M 

PROVIDER: S-EPMC12714872 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature